Signet Healthcare Partners
Overview
Signet Healthcare Partners is a growth equity firm founded in 1998 that provides growth capital to innovative, commercial-stage healthcare companies. The firm focuses on specialty pharmaceuticals, medical devices, diagnostics, and pharmaceutical services, investing in companies that are revenue-generating or preparing for commercial launch. Signet acts as an active, lead investor, taking significant minority or majority equity positions and participating at the board level to partner with management teams. The firm has raised funds with aggregate capital commitments exceeding $600 million and has invested in over 55 companies. It is currently investing out of its fifth fund.
Portfolio Companies
8
Website
signethealthcarepartners.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| PainTEQ | Aug 2025 | Recap | Lead |
| leon-nanodrugs GmbH | Aug 2024 | Series D | Co-investor |
| Laxai Life Sciences | Oct 2022 | Private Equity | Lead |
| Ascendia Pharmaceutical Solutions | Apr 2021 | Growth Equity | Lead |
| Altasciences | Feb 2021 | Buyout/LBO | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.